XABT

XABT is a China-based in vitro diagnostics and medical technology company focused on pathogen detection and infectious disease testing. The company develops and manufactures molecular diagnostic reagents, sample preparation products, automated instruments, rapid antigen tests, and sequencing-related solutions for hospitals, CDC systems, customs, research institutions, third-party labs, and self-testing markets. Its core capabilities center on multiplex PCR, immunochromatography, high-throughput sequencing, and laboratory automation, with a portfolio of more than 800 diagnostic reagents and multiple NMPA-cleared products. XABT also operates GMP-compliant production facilities and exports through a global distributor network. The business is best characterized as a commercial infectious-disease diagnostics company rather than a therapeutic drug developer.